June 13 (Reuters) - FibroGen Inc FGEN.O:
FIBROGEN INC - ON JUNE 12 ENTERS TERMINATION, ASSET TRANSFER AND LICENSE AGREEMENT WITH HIFIBIO - SEC FILING
FIBROGEN INC - AGREEMENT TERMINATES EXCLUSIVE LICENSE AND OPTION AGREEMENT - SEC FILING
Further company coverage: FGEN.O
((Reuters.Briefs@thomsonreuters.com;))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.